QR Pharma Develops Drugs To Treat Alzheimer’s Disease
Alzheimer’s disease affects more than 26 million people worldwide. This number is expected to grow to more than 106 million in 2050. Its economic burden and impact on patient wellness and quality of life for both patients and their caregivers is crushing.